US Business

Two high-ranking executives who oversaw Boeing’s development of the 737 MAX told House investigators the company’s design process wasn’t flawed despite two fatal crashes, a contrast to other company leaders’ concessions of past engineering errors.

The company has ended a pause in clinical trials for its experimental coronavirus vaccine in the U.K. after regulators concluded it was safe to do so. The trials were halted globally after a person who received the vaccine had an unexplained illness.

The biotech drugmaker has a market value of roughly $10 billion, meaning that Gilead would be paying up for the company and its prized breast-cancer drug.

The Japanese technology conglomerate is nearing another big asset sale—of Arm Holdings to Nvidia—that would create a chip-industry powerhouse.

While companies like Uber, Lyft and DoorDash have fought AB-5 in court, the law has unintentionally limited job opportunities for some other freelance workers.

Warner Bros. is postponing the release of its Wonder Woman sequel by more than two months, signaling that Hollywood studios fear U.S. moviegoers are hesitant to return to theaters.

With the fate of the video-sharing app being debated at the highest levels in Washington, Beijing and Silicon Valley, interim head Vanessa Pappas is looking to keep things running amid the high-stakes geopolitical drama.

Citigroup’s appointment of Jane Fraser as its next chief executive reflects efforts to elevate women across banking, though many say work remains to transform the industry.

Those who know the chief executive say he’s a thoughtful, kind person whose low-key style helped him get the job. He’s now contending with possible antitrust lawsuits, a recent revenue drop and pressure to take the company in new directions.

Rio Tinto said its chief executive would step down as it battles to contain the fallout from the destruction of two ancient rock shelters in northwestern Australia’s minerals-rich Pilbara region that were culturally significant to a local indigenous group.